Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
Recent reports suggest the number of investigations using misleading information to support applications for admission to schools has increased tenfold since 2010/11. Current estimates now top 1,000 across England with at least 40% resulting in an offer or place being withdrawn. The most common type of misleading information was using a false address but others included claiming a child was baptised in order to gain priority at a church school.
The actual figures may be much higher given the survey was limited to local authorities, only 50% of which responded, and appears not to have taken account of academies which are responsible for their own admission decisions. There may be many reasons for this rise in fraudulent applications and the greater number of places being withdrawn under the freedoms allowed under the School Admissions Code 2012. However, action is necessary to ensure the admission system remains fair to all parents and increased withdrawal of places can only send the right message to reinforce that principle.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Partner
Select which mailings you would like to receive from us.
Sign up